Literature DB >> 8213070

Morphological assessment of ethyl choline mustard aziridinium-induced neurotoxicity in rat brain reaggregate cultures.

H B Jones1, A M Pillar, A K Prince.   

Abstract

Foetal rat brain reaggregate cultures have been employed to investigate the morphological changes associated with the neurotoxic action of ethylcholine mustard aziridinium (ECMA). In a companion study we provided evidence for apparent selective cholinergic neurotoxicity. Exposure of 9-day-old cultures to 12.5 microM ECMA for 3 days produced dilatation of selected axon preterminals and terminals in the outer core tissue layer. Axoplasm in these dilated terminals was electron lucent and contained a flocculent, plasma-like material with remnants of the smooth endoplasmic reticulum. Their synaptic vesicle content was much reduced or, absent. Microglial cells were engaged in phagocytosis of these effete structures and a few necrotic neurons were enveloped by glial processes. Exposure to 50 microM ECMA produced widespread necrosis with some surviving neurons, surrounded by the still-persisting capsular layer. Treatment with 100 microM ECMA generated a greater extent of tissue necrosis, with only a few surviving neurons and glial cells being contained within the necrotic tissue mass. Reaggregates frequently disintegrated following capsule loss. Our results indicate that the initial morphological manifestation of ECMA-induced toxicity is dilatation of axon terminals, that are probably of cholinergic origin and are targeted due to their possession of the high-affinity choline transport system which is unique to these neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213070     DOI: 10.1007/bf00334882

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Chemical reactions of the nitrogen mustard gases; the transformations of methyl-bis(beta-chloroethyl)amine in water.

Authors:  C GOLUMBIC; J S FRUTON; M BERGMANN
Journal:  J Org Chem       Date:  1946-09       Impact factor: 4.354

2.  Effects of AF64A on cholinergic neurotransmission in the sixth abdominal ganglion of the cockroach.

Authors:  Y Morio; O Yagasaki
Journal:  Comp Biochem Physiol C       Date:  1989

3.  Properties of a calcium-activated protease in squid axoplasm which selectively degrades neurofilament proteins.

Authors:  H C Pant; H Gainer
Journal:  J Neurobiol       Date:  1980

4.  Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine.

Authors:  D F Emerich; T J Walsh
Journal:  Exp Neurol       Date:  1991-06       Impact factor: 5.330

5.  Cholinergic neurotoxicity induced by ethylcholine aziridinium (AF64A) in neuron-enriched cultures.

Authors:  D L Davies; N Sakellaridis; T Valcana; A Vernadakis
Journal:  Brain Res       Date:  1986-07-23       Impact factor: 3.252

6.  Atrophy of cholinergic neurons within the rat nucleus basalis magnocellularis following intracortical AF64A infusion.

Authors:  P R Mouton; G W Arendash
Journal:  Neurosci Lett       Date:  1990-03-26       Impact factor: 3.046

7.  Acute in vivo exposure to ethylcholine aziridinium (AF64A) depresses the secretion of quanta from motor nerve terminals.

Authors:  J J McArdle; I Hanin
Journal:  Eur J Pharmacol       Date:  1986-11-12       Impact factor: 4.432

8.  The toxic effects of ethylcholine mustard aziridinium ion on cholinergic cells in the chicken retina.

Authors:  T J Millar; I Ishimoto; M Boelen; M L Epstein; C D Johnson; I G Morgan
Journal:  J Neurosci       Date:  1987-02       Impact factor: 6.167

9.  Kinetics of irreversible inhibition of choline transport in synaptosomes by ethylcholine mustard aziridinium.

Authors:  D Curti; R M Marchbanks
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

10.  Triodothyronine enhancement of neuronal differentiation in aggregating fetal rat brain cells cultured in a chemically defined medium.

Authors:  P Honegger; D Lenoir
Journal:  Brain Res       Date:  1980-10-20       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.